文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

埃塞俄比亚亚的斯亚贝巴产前均衡能量与蛋白质补充的靶向策略:一项随机有效性研究的研究方案

Targeting strategies of antenatal balanced energy and protein supplementation in Addis Ababa, Ethiopia: study protocol for a randomized effectiveness study.
PubMed 文献 · Trials · 2024-04-30

本研究将在埃塞俄比亚亚的斯亚贝巴两个分区开展随机有效性研究,纳入5400名孕24周及以内、18至49岁孕妇,比较三种靶向策略与普遍补充策略对不良妊娠结局的有效性、成本效果及实施情况。

要点

  • 研究纳入孕24周及以内孕妇5400名,每组1350名,比较四种产前均衡能量与蛋白质补充策略。
  • 靶向策略基于基线营养状况(BMI<18.5 kg/m2或上臂中围<23 cm)和/或月度妊娠期体重增长监测。
  • 主要比较不同策略预防不良妊娠结局的有效性与成本效果,并评估可行性、可接受性和实施情况。

核心结论

  • 本研究将为产前均衡能量与蛋白质补充的有效且具成本效益的全球建议和操作指南提供依据。
  • 靶向策略有潜力在埃塞俄比亚及其他孕妇营养不足负担高的低资源地区扩大推广。

研究设计与样本

  • 在埃塞俄比亚亚的斯亚贝巴两个分区开展随机有效性研究,评估不同产前均衡能量与蛋白质补充靶向策略的有效性、成本效果和实施情况。
  • 纳入18至49岁、孕24周及以内、在九家研究卫生机构之一接受产前检查的孕妇,共5400名,每组1350名。
  • 在六家卫生机构中,参与者随机分入三组:对照组(第1组)、基于基线营养状况的靶向补充组(第2组)、基于基线营养状况和月度妊娠期体重增长监测的靶向补充组(第3组)。
  • 在其余三家机构中,参与者分配至普遍补充组(第4组)。
  • 参与者每月随访至分娩,分娩后72小时内和产后6周评估母婴健康状况。

主要发现

  • 第2组和第3组参与者在入组时存在营养不足(基线体重指数小于18.5 kg/m2或上臂中围小于23 cm)方接受补充。
  • 第3组除基于基线营养不足靶向外,还通过定期体重测量识别妊娠期体重增长不足并启动额外补充。
  • 第4组参与者无论基线营养状况或妊娠期体重增长如何,均接受补充直至妊娠结束。
  • 所有参与者均接受标准产前保健,包括铁和叶酸补充。

关键数值与推荐

  • 营养不足定义为基线体重指数小于18.5 kg/m2或上臂中围小于23 cm。
  • 纳入标准为年龄18至49岁、孕24周或以下、在九家研究卫生机构之一接受产前检查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antenatal balanced energy and protein (BEP) supplements have well-documented benefits for pregnancy outcomes. However, considerable practical gaps remain in the effective and cost-effective delivery of antenatal BEP supplements at scale in low- and middle-income countries. METHODS: A randomized effectiveness study will be conducted in two sub-cities of Addis Ababa, Ethiopia, to evaluate the effectiveness, cost-effectiveness, and implementation of different targeting strategies of antenatal BEP supplements. Pregnant women aged 18 to 49, with a gestational age of 24 weeks or less, and attending antenatal visits in one of the nine study health facilities are eligible for enrollment. In six of the health facilities, participants will be randomized to one of three study arms: control (Arm 1), targeted BEP provision based on baseline nutritional status (Arm 2), and targeted BEP supplementation based on baseline nutritional status and monthly gestational weight gain (GWG) monitoring (Arm 3). In the remaining three facilities, participants will be assigned to universal BEP provision (Arm 4). Participants in Arms 2 and 3 will receive BEP supplements if they have undernutrition at enrollment, as defined by a baseline body mass index less than 18.5 kg/m2 or mid-upper arm circumference less than 23 cm. In Arm 3, in addition to targeting based on baseline undernutrition, regular weight measurements will be used to identify insufficient GWG and inform the initiation of additional BEP supplements. Participants in Arm 4 will receive BEP supplements until the end of pregnancy, regardless of baseline nutritional status or GWG. All participants will receive standard antenatal care, including iron and folic acid supplementation. A total of 5400 pregnant women will be enrolled, with 1350 participants in each arm. Participants will be followed up monthly during their visits to the antenatal facilities until delivery. Maternal and infant health status will be evaluated within 72 h after delivery and at 6 weeks postpartum. The effectiveness and cost-effectiveness of the different BEP targeting strategies in preventing adverse pregnancy outcomes will be compared across arms. Qualitative data will be analyzed to assess the feasibility, acceptability, and implementation of different supplementation strategies. DISCUSSION: This study will inform global recommendations and operational guidelines for the effective and cost-effective delivery of antenatal BEP supplements. The targeted approaches have the potential for broader scale-up in Ethiopia and other low-resource settings with a high burden of undernutrition among pregnant women. TRIAL REGISTRATION: ClinicalTrials.gov registration number: NCT06125860. Registered November 9, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang D, Shifraw T, Costa JC, et al. Targeting strategies of antenatal balanced energy and protein supplementation in Addis Ababa, Ethiopia: study protocol for a randomized effectiveness study. Trials. 2024. PMID: 38689304. doi:10.1186/s13063-024-08002-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。